CONCLUDED Stock Market News From Sept. 18, 2025: Dow, S&P 500, Nasdaq Hit New Highs Last Updated: Updated 10 hours ago Stock Futures Surge After Fed Signals Further Rate Cuts By Patrick O'Donnell Stocks looked set to open in the green Thursday after the Federal Reserve delivered the interest-rate cut the market has long desired. Fed Chair Jerome Powell also signaled further easing, which buoyed investors. Subscribe to Barron's Tools Customer Service Customer Center Cryptocurrencies Data Magazine Markets Sto ...

The Federal Reserve on Wednesday cut interest rates for the first time in 2025 and released policymakers' quarterly forecast of economic conditions that shows the potential outlook for further rate cuts, as well as inflation and the labor market. The 25-basis-point cut lowered the benchmark federal funds rate to a new range of 4% to 4.25%, after rates were held steady at the first five meetings of this year amid economic uncertainty regarding the labor market and inflation amid tariff shifts and immigration ...

American Express unveiled long-awaited upgrades to its U.S. Platinum cards on Thursday, adding new perks worth over $3,500 annually while raising the annual fee by $200. ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Needham analyst Gil Blum upgraded Amicus Therapeutics, Inc. FOLD from Hold to Buy and announced a $14 price target. Amicus Therapeutics shares closed at $7.97 on Wednesday. See how other analysts view this stock.RBC Capital analyst Walter Spracklin upgraded the rating for CSX Corporation CSX from Sector Perfo ...

''DividendRank'' statistics including a strong 2.3% yield, as well as a superb track record of at least two decades of dividend growth, according to the most recent Illinois Tool Works, Inc. (Symbol: ITW) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-averagestatistics including a strong 2.3% yield, as well as a superb track record of at least two decades of dividend growth, according to the most recent ''DividendRank'' report.According to the ETF Finder at ETF Ch ...

Nissan Motor Company has announced a strategic consolidation of its global design network, which will result in the closure of its design studios in San Diego, US, and São Paulo, Brazil. The restructuring is part of the automaker's “Re:Nissan” plan, which seeks to create an “agile” and technology-focused organisation prepared for the future. As the company aims to streamline its design operations, Nissan Design America (NDA) and Nissan Design Latin America (NDLA) will wind down their activities. The Jap ...

Core Insights - The Invesco DB Precious Metals ETF (DBP) is a smart beta ETF launched on January 5, 2007, providing broad exposure to the Precious Metals ETFs category [1] - DBP is managed by Invesco and has accumulated over $208.33 million in assets, making it an average-sized ETF in its category [5] - The ETF aims to match the performance of the DBIQ Optimum Yield Precious Metals Index Excess Return, which is based on futures contracts for gold and silver [6] Fund Characteristics - DBP has an annual operating expense ratio of 0.76%, which is considered high in the ETF space, and a 12-month trailing dividend yield of 3.07% [7] - The ETF's top holding, Comex Gold 100 Troy Ounces Future-12-29-2025, constitutes approximately 80.68% of total assets, indicating a concentrated exposure [8] - The top 10 holdings account for about 182.3% of total assets under management, suggesting significant overlap or leverage in the portfolio [9] Performance Metrics - As of September 18, 2025, DBP has gained approximately 37.44% year-to-date and 37.83% over the past year, with a trading range between $60.30 and $84.47 in the last 52 weeks [10] - The ETF has a beta of 0.14 and a standard deviation of 16.98% over the trailing three-year period, categorizing it as a medium-risk investment [11] Alternatives and Market Position - While DBP is a viable option for investors looking to outperform the Precious Metals ETFs segment, alternatives like the abrdn Physical Precious Metals Basket Shares ETF (GLTR) exist, which has $1.67 billion in assets and a lower expense ratio of 0.60% [12] - Investors seeking lower-cost and lower-risk options may consider traditional market cap weighted ETFs that aim to match the returns of Precious Metals ETFs [13]

The report, titled 'China Country Report: Macroeconomic and Sustainability Analysis,' uses data from the Higg Facility Environmental Module (Higg FEM), a tool designed by Cascale to evaluate the environmental impact of manufacturing facilities. The Higg FEM assesses factory performance in areas such as energy use, emissions, water, wastewater, and chemical management. Higg Index senior vice president Jeremy Lardeau said: “Cascale’s Higg FEM data is a powerful lens into where the industry is headed. China ...

Splenda owner Heartland Food Products Group has acquired the rights to the SlimFast brand in North America from Irish food ingredients group Glanbia. The financial terms of the transaction remain undisclosed. Heartland is known for producing the Splenda branded low-calorie sweeteners, along with drink mixes, coffee and nutritional beverages. In a statement, Glanbia said the deal relates to the sale of SlimFast in the US and "certain other jurisdictions". A Glanbia spokesperson told Just Drinks the othe ...

Core Viewpoint - A class action lawsuit has been filed against RxSight, Inc. for alleged violations of the Securities Exchange Act of 1934, focusing on misleading statements regarding the company's growth and performance during the specified Class Period [1][4]. Company Overview - RxSight, Inc. is a commercial-stage medical technology company specializing in cataract treatment, with its main product being the RxSight Light Adjustable Lens system, which includes an intraocular light adjustable lens and a light delivery device [3]. Allegations of the Lawsuit - The lawsuit claims that RxSight and its executives misrepresented the company's growth, stating that utilization was rising and that newer customer cohorts were adopting the technology at a comparable or faster rate than previous cohorts. In reality, the company faced challenges with its field organization, leading to slower adoption and declining utilization [4]. - The lawsuit highlights that incremental placements of light delivery devices did not result in the expected volume of lens procedures, undermining the company's growth model [4]. Impact of Disclosures - On April 2, 2025, RxSight reported a sequential decline in quarterly lens sales and reduced its full-year revenue guidance by approximately $24 million, resulting in a 38% drop in the stock price [5]. - Further disclosures on July 8, 2025, revealed a 45% sequential decline in light delivery device sales and a second consecutive quarter of declining lens sales, leading to another 38% decrease in stock price [6]. Legal Representation - The plaintiffs in the lawsuit are represented by Robbins Geller Rudman & Dowd LLP, a law firm with significant experience in prosecuting investor class actions related to financial fraud [7].